Status:
COMPLETED
The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS
Lead Sponsor:
Region Skane
Conditions:
IBS - Irritable Bowel Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the present study is to research whether subjects with irritable bowel syndrome (IBS) display epigenetic/genetic changes or altered microbiota compared to a non-IBS control group. Further, ...
Detailed Description
The study will be performed on 140 subjects with verified IBS. Patients will be recruited from the clinic of Gastroenterology or Internal medicine as well as primary health care centers. At the start ...
Eligibility Criteria
Inclusion
- Verified IBS according to Rom IV criteria.
Exclusion
- Serious mental or somatic disease
- Abuse
- Inability to understand he Swedish language
- Already on a diet (e.g. vegan, FODMAP, gluten-free).
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2019
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03306381
Start Date
January 15 2018
End Date
February 28 2019
Last Update
December 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deartment of INternal Medicine
Malmo, Sweden, 20502